Evaluation of Alpha-1 Antitrypsin as a Prognostic Biomarker in Severe Influenza: A Prospective Study

Background: Influenza is a global health issue involving inflammatory mediators, the imbalances of which contribute to pulmonary and extrapulmonary damage. Objectives: To evaluate whether AAT1 levels are elevated in patients with severe influenza and assess its potential as a prognostic biomarker. Materials and methods: A prospective, analytical, non-interventional study was conducted on 72 patients admitted for severe influenza to the Internal Medicine Department at “Lozano Blesa” University Hospital (Zaragoza, Spain). Blood AAT1 concentrations at admission were analyzed alongside clinical and biochemical variables. Results: The mean patient age was 80.31 years (54.2% female). Overall mortality was 4.17%, one patient required ICU admission, and five had SARS-CoV-2 coinfection. Mean AAT1 concentration was 164.1 mg/dL (normal range: 100–200 mg/dL). AAT1 levels correlated significantly with leukocyte counts and C-reactive protein (r = 0.582, p < 0.001). Leukocyte counts were significantly higher in the patient requiring intensive care. Notably, AAT1 concentrations were significantly higher in patients with SARS-CoV-2 coinfection compared to non-coinfected influenza cases (p < 0.05). Conclusions: Admission AAT1 concentration does not serve as a useful prognostic biomarker in severe influenza. However, elevated AAT1 levels at diagnosis in hospitalized patients should prompt consideration of SARS-CoV-2 coinfection. Further research is warranted to clarify AAT1 involvement in influenza pathophysiology.

Authors

Institutions

Publication Details

Journal
Biomolecules
Published
2026-11-18
DOI
https://doi.org/10.3390/biom16111675
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of Alpha-1 Antitrypsin as a Prognostic Biomarker in Severe Influenza: A Prospective Study

Miguel Ángel Torralba-Cabeza, Susana Olivera, Inmaculada Moreno-Gázquez, Juan José Perales-Afán et al.
2 links
Biomolecules
Influenza Virus Research Studies
article

Evaluation of Alpha-1 Antitrypsin as a Prognostic Biomarker in Severe Influenza: A Prospective Study

Miguel Ángel Torralba-Cabeza, Susana Olivera, Inmaculada Moreno-Gázquez, Juan José Perales-Afán, Susana Torralba-Aznárez, Almudena García-Gutiérrez, Isabel Franco-Burgos, Sebastián Menao-Guillén, Mónica Ramos-Álvarez, María-Ángel Julián-Ansón
article en

Abstract

Background: Influenza is a global health issue involving inflammatory mediators, the imbalances of which contribute to pulmonary and extrapulmonary damage. Objectives: To evaluate whether AAT1 levels are elevated in patients with severe influenza and assess its potential as a prognostic biomarker. Materials and methods: A prospective, analytical, non-interventional study was conducted on 72 patients admitted for severe influenza to the Internal Medicine Department at “Lozano Blesa” University Hospital (Zaragoza, Spain). Blood AAT1 concentrations at admission were analyzed alongside clinical and biochemical variables. Results: The mean patient age was 80.31 years (54.2% female). Overall mortality was 4.17%, one patient required ICU admission, and five had SARS-CoV-2 coinfection. Mean AAT1 concentration was 164.1 mg/dL (normal range: 100–200 mg/dL). AAT1 levels correlated significantly with leukocyte counts and C-reactive protein (r = 0.582, p < 0.001). Leukocyte counts were significantly higher in the patient requiring intensive care. Notably, AAT1 concentrations were significantly higher in patients with SARS-CoV-2 coinfection compared to non-coinfected influenza cases (p < 0.05). Conclusions: Admission AAT1 concentration does not serve as a useful prognostic biomarker in severe influenza. However, elevated AAT1 levels at diagnosis in hospitalized patients should prompt consideration of SARS-CoV-2 coinfection. Further research is warranted to clarify AAT1 involvement in influenza pathophysiology.

BiomoleculesVol. 16(11)
Universidad de Zaragoza (ES), Sociedad Española de Medicina Interna (ES), Sociedad Española de Medicina de Familia y Comunitaria (ES), Hospital Clínico Universitario Lozano Blesa (ES), Instituto de Investigación Sanitaria Aragón (ES)
Good health and well-being
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon